References
1.S.C. Prasad, S. Kotigadde, M. Shekhar, et al.Primary otomycosis in the
Indian subcontinent: predisposing factors, microbiology, and
classification.Int J Microbiol, 2014 (2014), pp. 1-9
2.F. Khan, R. Muhammad, M.R. Khan, et al. Efficacy of topical
clotrimazole in treatment of otomycosis.J Ayub Med Coll
Abbottabad, 25 (2013), pp. 78-80
3.H. Nowrozi, F.D. Arabi, H.G. Mehraban, et al.Mycological and clinical
study of otomycosis in Tehran, Iran.Bull Environ Pharmacol Life
Sci, 3 (2014), pp. 29-31
4.Moharram AM, Ahmed HE, Nasr SAM: Otomycosis in Assiut, Egypt. J Basic
Appl Mycol 4, 1–11 (2013)
5.Anwar K, Gohar MS: Otomycosis; clinical features, predisposing factors
and treatment implications. Pak J Med Sci 30, 564–567 (2014)
6.De
la Paz Cota BR,
Cepero
Vega PP. Efficacy and safety of eberconazole 1% otic solution compared
to clotrimazole 1% solution in patients
with otomycosis.Am J
Otolaryngol. 2018 May - Jun;39(3):307-312.
7.B. Barati, S. Okhovvat, A. Goljanian, et al.Otomycosis in central
Iran: a clinical and mycological study.Iran Red Crescent Med
J, 13 (2011), pp. 873-876
8.T. Ho, J. Vraben, D. Yoo, N. Coker. Otomycosis: clinical features and
treatment implications. Otolaryngol Head Neck Surg, 135 (2006),
pp. 787-791
9.Peng YX, Diagnosis and Treatment of Otitis Externa Mycotica:
Experiences with 216 Cases.Chinese Journal of Otology Vo1.17,No.4 , 2019
10. Jia X, Liang Q, Chi F, et al. Otomycosis in Shanghai: Aetiology,
clinical features and therapy. Mycoses 55, 404–409 (2012)
11.Abdelazeem M, Gamea A, Mubarak H, et al. Epidemiology, causative
agents, and risk factors affecting human otomycosis infections. Turk J
Med Sci 45, 820–826 (2015)
12. Mohammed
Rifaat
Ahmed, Ashraf
Saad
Abou-Halawa, Waheed
F. Hessam,et al.A search for new otomycotic species and their
sensitivity to different
antifungals.Interv
Med Appl Sci. 2018 Sep; 10(3): 145–149.
13.Agarwal P, Devi L S. Otomycosis in a Rural Community Attending a
Tertiary Care Hospital: Assessment of Risk Factors and Identification of
Fungal and Bacterial Agents. J Clin Diagn Res. 2017;11(06):DC14–DC18.
14.A.A. Malik, S.N. Malik, M.A. Aslam, et al. Comparative efficacy of
topical clotrimazole and 3% salicylic acid in otomycosis.Rawal Med
J, 13 (2012), pp. 46-49
15. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western
Nigeria.Mycoses. 2008;51(1):67-70.
16.C. Linstrom, F. Lucente.Diseasesof the external
ear.J. Bailey, T. Johnson, D. Newlands (Eds.), Head& neck
surgery-otolaryngology, Lippincott Williams &
Wilkins, Philadelphia,PA (2014), pp. 1987-2002
17.Satish H S, Viswanatha B, Manjuladevi M. A Clinical Study of
Otomycosis. IOSR J Dental Med Sci. 2013;5(02):57–62.
18.Li
Y, He
L. Diagnosis and treatment of otomycosis in southern
China.Mycoses. 2019
Nov;62(11):1064-1068.
19. Ren Y, Zhang Q, Yu Z, et al. Clinical analysis of external ear canal
coating by otoendoscopy on otomycosis external with triamcinolone
acetonide and econazole nitrate cream. Lin Chung Er Bi Yan HouTou Jing
Wai Ke Za Zhi. 2015;29:1304‐1305.